VITRAKVI

Identification of Vitrakvi

No description

Google image searchProduct monograph

Active ingredient

larotrectinib (larotrectinib sulfate), 25 MG

DIN: 02490315

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BAYER INC

Date: 13-NOV-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX12 — LAROTRECTINIB (ATC/DDD)

External Links for Vitrakvi

Search on Google

• Vitrakvi side effects
• Vitrakvi dosage
• larotrectinib side effects
• larotrectinib dosage

Bayer Inc

Go to Bayer website to see drug product details. Sometimes you can find vitrakvi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.